Rocket Pharmaceuticals, Inc. General Counsel Martin Wilson filed a Form 4 on November 20, 2026, disclosing the sale of 677 shares of common stock on November 18, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.
Key Highlights
- Reporting person: Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
- Transaction date: November 18, 2026
- Shares disposed: 677 shares of common stock, sold at $2.178 per share
- Purpose: According to the filing, shares were sold "to pay tax withholding obligations in connection with the vesting of RSUs"
- Beneficial ownership following transaction: 540,336 shares held directly, including RSUs that convert to common stock on a one-for-one basis
- Ownership form: Direct
Wilson's RSU-Related Share Disposal at Rocket Pharmaceuticals
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Martin Wilson, serving as General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), disposed of 677 shares of common stock on November 18, 2026. The transaction was coded "S," indicating a sale, at a price of $2.178 per share. The filing states that the shares were sold by the reporting person "in order to pay tax withholding obligations in connection with the vesting of RSUs."
The filing notes that Wilson's reported holdings include restricted stock units that convert to common stock on a one-for-one basis. Following the reported transaction, Wilson's total direct beneficial ownership stands at 540,336 shares, per the filing. No derivative securities transactions were reported in Table II of the form.
The Form 4 was filed by one reporting person and covers a single transaction. No amendment date was indicated, suggesting this is an original filing. The form was signed on November 20, 2026, and lists Wilson's address as care of Rocket Pharmaceuticals, Inc., 9 Cedarbrook Drive, Cranbury, New Jersey 08512.
What Was Disclosed
Rocket Pharmaceuticals General Counsel Martin Wilson reported the sale of 677 shares of common stock at $2.178 per share on November 18, 2026, solely to satisfy tax withholding obligations arising from RSU vesting, leaving him with 540,336 shares beneficially owned directly.



Please wait processing your request...